Pular para o conteúdo principal
Ranking Invest

MGTX - MeiraGTx Holdings plc

Segmento: HealthcareMeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Análise Ranking Invest

Valuation estimado
-8,45%
-$ 29.64 Mi
Valor de Mercado
$ 1.23 Bi
Desconto (AV)-4246.1%
IVR
-0.02A companhia vale -0,02 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.21O valuation alternativo equivale a -21% do valor de mercado da companhia.
MLL
-0.21O lucro líquido dos controladores em 16 trimestres equivale a -21% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 215.36 Mi

Dívida Líquida

-$ 143.17 Mi

L4T

$ 78.98 Mi

MM4T

-7014.18%

Indicadores Básicos

ROE

36.67%

Índices de Previsibilidade

Receita Líquida

G6.80

Lucro

D0.54

Margem

E1.16

Índices de Tendência

Receita Líquida

C5.02

Lucro

D-0.41

Margem

E-3.90

Índices de Endividamento

DIV/PAT

-0.66

DIV/L4T

-1.81

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.